Medicare utilization — KEVIN E SHERER (MD)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J2356 | Injection, tezepelumab-ekko, 1 mg | 13,440 | 14 | $0 | $195,217 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 979 | 615 | $0 | $89,047 |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | 245 | 240 | $0 | $7,132 |
| 94729 | Test to examine how well the lungs exchange gases | 234 | 229 | $0 | $9,538 |
| 94726 | Test to determine lung volumes using sensors | 231 | 226 | $0 | $9,270 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·